Bridion

Active Ingredient(s): Sugammadex
FDA Approved: * December 15, 2015
Pharm Company: * ORGANON USA INC
Category: Anesthetic

Sugammadex, sold by Merck & Co., Inc. (USA) under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium[2][4] in general anaesthesia. It is the first selective relaxant binding agent (SRBA). The most common side effects include cough, airway problems due to the anaesthesia wearing off, reduced blood pressure and other complications such as changes in heart rate.[3] Contents ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bridion 100 mg/ml Intravenous Injection, Solution

NDC: 0006-5423

Labeler:

Merck Sharp & Dohme Corp.

Bridion 100 mg/ml Intravenous Injection, Solution

NDC: 0006-5425

Labeler:

Merck Sharp & Dohme Corp.

Bridion 100 mg/ml Intravenous Injection, Solution

NDC: 71872-7187

Labeler:

Medical Purchasing Solutions, LLC